Top Markets
Coin of the day
Alseres Pharmaceuticals, Inc. Alseres Pharmaceuticals, Inc.

Alseres Pharmaceuticals, Inc.

ALSE
株式のランク #42806
Alseres Pharmaceuticals, Inc. focuses on creating both diagnostic and... Alseres Pharmaceuticals, Inc. focuses on creating both diagnostic and therapeutic solutions, with a primary emphasis on ailments affecting the central nervous system. Their flagship experimental compound is Altropane, a molecular imaging agent developed for identifying and diagnosing Parkinson's disease and dementia. Founded in 1972, the company was previously known as Boston Life Sciences, Inc. before officially changing its name to Alseres Pharmaceuticals, Inc. in June 2007. Its operations are headquartered in Auburndale, Massachusetts.
株価
$0.01
最終同期: 2024-08-19
時価総額
$61.27
変化(1日)
0.00%
変化(1年)
0.00%
US
取引 Alseres Pharmaceuticals, Inc. (ALSE)

カテゴリー

Alseres Pharmaceuticals, Inc.(ALSE)のEPS
2026 時点のEPS TTM: 0
Alseres Pharmaceuticals, Inc.の最新の財務報告と株価によると、同社の現在のEPS(TTM)は0です。2026年末には、EPSは0で、2026年のEPS0と同等でした。
Alseres Pharmaceuticals, Inc.のEPS履歴(2026から2026まで)
各年末時点のEPS
EPS 変化
提供された日付のデータは十分ではありません。
同様の企業または競合他社のEPS